INS-20 is a chemically modified version of GCSF in which a water soluble polymer called polyethylene glycol is attached to the protein. The pegylated protein has a prolonged biological activity after it is injected into the patient. This allows less frequent dosing for the patient compared to GCSF.

• Follow-On Biologics
• INS-19
• INS-20
• INS-21
• INS-22
• Proprietary Protein
• Iplex
• Oncology Programs

Press Releases

• May. 8, 2008
  Insmed Announces First Quarter 2008 Financial Results Read More
• May. 8, 2008
  /C O R R E C T I O N -- Insmed Inc./ Read More